Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database
CONCLUSIONS: Risk factors predictive of thrombosis in ovarian cancer patients are not consistent between ATE and VTE, thus thrombotic events should not be combined for analysis. Differential thrombosis risk assessment is needed to improve prevention strategies and guide thromboprophylaxis for these patients.PMID:38382168 | DOI:10.1016/j.ygyno.2024.02.011 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Sydney Penfound Alexandra Lukey Jessica Hodgson Wilma M Hopman Gillian E Hanley Maha Othman Source Type: research

Racial disparities in endometrial cancer: Where are we after 26  years?
CONCLUSION: Racial disparities in disease incidence and mortality in endometrial cancer rates between WAW and AAW have widened during a 26-year period of robust research, suggesting that current research alone is not enough to eliminate this disparity. Based on this rapid systematic review we have identified and analyzed the impact of causation variables on this disparity. Additionally, we have made strong and pertinent recommendations for the benefit of mitigating this escalating racial disparity.PMID:38382150 | DOI:10.1016/j.ygyno.2024.01.054 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Michael L Hicks Maya M Hicks Roland P Mathews Dineo Khabele Camille A Clare Onyinye Balogun Yolanda R Lawson Ronda Henry Tillman Raleigh Butler Cyril O Spann Groesbeck P Parham Source Type: research

Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women
CONCLUSIONS: No marked associations between use of fertility drugs and borderline ovarian tumors were observed. However, the cohort's relatively young age at end of follow-up emphasizes the importance of extending the follow-up period for women who have used fertility drugs.PMID:38382167 | DOI:10.1016/j.ygyno.2024.02.013 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Anna Kj ær Kristensen Clarissa Lima Brown Frandsen Bugge N øhr Jakob Hansen Viuff Marie Hargreave Kirsten Frederiksen Susanne K Kj ær Allan Jensen Source Type: research

Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database
CONCLUSIONS: Risk factors predictive of thrombosis in ovarian cancer patients are not consistent between ATE and VTE, thus thrombotic events should not be combined for analysis. Differential thrombosis risk assessment is needed to improve prevention strategies and guide thromboprophylaxis for these patients.PMID:38382168 | DOI:10.1016/j.ygyno.2024.02.011 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Sydney Penfound Alexandra Lukey Jessica Hodgson Wilma M Hopman Gillian E Hanley Maha Othman Source Type: research

Racial disparities in endometrial cancer: Where are we after 26  years?
CONCLUSION: Racial disparities in disease incidence and mortality in endometrial cancer rates between WAW and AAW have widened during a 26-year period of robust research, suggesting that current research alone is not enough to eliminate this disparity. Based on this rapid systematic review we have identified and analyzed the impact of causation variables on this disparity. Additionally, we have made strong and pertinent recommendations for the benefit of mitigating this escalating racial disparity.PMID:38382150 | DOI:10.1016/j.ygyno.2024.01.054 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Michael L Hicks Maya M Hicks Roland P Mathews Dineo Khabele Camille A Clare Onyinye Balogun Yolanda R Lawson Ronda Henry Tillman Raleigh Butler Cyril O Spann Groesbeck P Parham Source Type: research

Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women
CONCLUSIONS: No marked associations between use of fertility drugs and borderline ovarian tumors were observed. However, the cohort's relatively young age at end of follow-up emphasizes the importance of extending the follow-up period for women who have used fertility drugs.PMID:38382167 | DOI:10.1016/j.ygyno.2024.02.013 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Anna Kj ær Kristensen Clarissa Lima Brown Frandsen Bugge N øhr Jakob Hansen Viuff Marie Hargreave Kirsten Frederiksen Susanne K Kj ær Allan Jensen Source Type: research

Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database
CONCLUSIONS: Risk factors predictive of thrombosis in ovarian cancer patients are not consistent between ATE and VTE, thus thrombotic events should not be combined for analysis. Differential thrombosis risk assessment is needed to improve prevention strategies and guide thromboprophylaxis for these patients.PMID:38382168 | DOI:10.1016/j.ygyno.2024.02.011 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Sydney Penfound Alexandra Lukey Jessica Hodgson Wilma M Hopman Gillian E Hanley Maha Othman Source Type: research

Racial disparities in endometrial cancer: Where are we after 26  years?
CONCLUSION: Racial disparities in disease incidence and mortality in endometrial cancer rates between WAW and AAW have widened during a 26-year period of robust research, suggesting that current research alone is not enough to eliminate this disparity. Based on this rapid systematic review we have identified and analyzed the impact of causation variables on this disparity. Additionally, we have made strong and pertinent recommendations for the benefit of mitigating this escalating racial disparity.PMID:38382150 | DOI:10.1016/j.ygyno.2024.01.054 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Michael L Hicks Maya M Hicks Roland P Mathews Dineo Khabele Camille A Clare Onyinye Balogun Yolanda R Lawson Ronda Henry Tillman Raleigh Butler Cyril O Spann Groesbeck P Parham Source Type: research

Risk of borderline ovarian tumors after fertility treatment - Results from a Danish cohort of infertile women
CONCLUSIONS: No marked associations between use of fertility drugs and borderline ovarian tumors were observed. However, the cohort's relatively young age at end of follow-up emphasizes the importance of extending the follow-up period for women who have used fertility drugs.PMID:38382167 | DOI:10.1016/j.ygyno.2024.02.013 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Anna Kj ær Kristensen Clarissa Lima Brown Frandsen Bugge N øhr Jakob Hansen Viuff Marie Hargreave Kirsten Frederiksen Susanne K Kj ær Allan Jensen Source Type: research

Incidence and risk factors of venous and arterial thromboembolic events among patients with ovarian cancer- data from a large Canadian database
CONCLUSIONS: Risk factors predictive of thrombosis in ovarian cancer patients are not consistent between ATE and VTE, thus thrombotic events should not be combined for analysis. Differential thrombosis risk assessment is needed to improve prevention strategies and guide thromboprophylaxis for these patients.PMID:38382168 | DOI:10.1016/j.ygyno.2024.02.011 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 21, 2024 Category: Cancer & Oncology Authors: Sydney Penfound Alexandra Lukey Jessica Hodgson Wilma M Hopman Gillian E Hanley Maha Othman Source Type: research

Determination of quality of life-related health utilities for surgical complications in ovarian cancer
CONCLUSIONS: This study establishes health state utilities for surgical complications associated with ovarian cancer. These utilities can be used in future cost-effectiveness evaluations to determine quality-adjusted outcomes and may help in counseling patients during the shared decision-making process.PMID:38377761 | DOI:10.1016/j.ygyno.2024.01.041 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 20, 2024 Category: Cancer & Oncology Authors: Rudy S Suidan Charlotte C Sun Amy K Schneider Karen H Lu Sharon H Giordano Larissa A Meyer Source Type: research

A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment
CONCLUSIONS: We believe our findings provide improved understanding of tumor-immune crosstalk in HGSOC TME highlighting the importance of the relationship between AKT and WNT pathways, immune cell function, and platinum response in HGSOC.PMID:38377762 | DOI:10.1016/j.ygyno.2024.02.008 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 20, 2024 Category: Cancer & Oncology Authors: Carly B Scalise Kaitlyn Kincaid Haley Thigpen Jennah Moore Bailee Dover Lyse Norian Selene Meza-Perez Troy Randall Michael Birrer Kunle Odunsi Rebecca C Arend Source Type: research

Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study
CONCLUSION: Survival outcomes were excellent in both cohorts of patients undergoing robotic vs. vaginal radical trachelectomy. The surgical approach was not significantly associated with risk of recurrence after adjusting for clinically important confounders.PMID:38377763 | DOI:10.1016/j.ygyno.2024.02.018 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 20, 2024 Category: Cancer & Oncology Authors: Andra Nica Anouk Benseler Ashna Parbhakar Ly-Ann Teo Fortin Marguerite Heyns Marette Lee Al Covens Marie Plante Taymaa May Source Type: research

Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy
CONCLUSION: In this population, inadequate follow up for abnormal cervical cytology during pregnancy is prominent, especially among those with younger maternal age, African American (AA) race, cervical cytology completed at later gestational ages of pregnancy, and low-grade initial cytology. Higher no-show rate among AA patients supports well-documented health disparities and need for further investigation and protocols to identify those at risk for loss to follow up.PMID:38368812 | DOI:10.1016/j.ygyno.2024.01.037 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 18, 2024 Category: Cancer & Oncology Authors: Kelsey A Roof Hannah K Wichmann Laura J Carlton Minh L Nguyen George G Birdsong Danielle M Blemur Lisa C Flowers Source Type: research

The impact of body mass index on robotic surgery outcomes in endometrial cancer
CONCLUSION: BMI does not affect the peri-operative outcome of patients undergoing robotic staging procedures for endometrial cancer.PMID:38368813 | DOI:10.1016/j.ygyno.2024.01.051 (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - February 18, 2024 Category: Cancer & Oncology Authors: Eva Kadoch Yoav Brezinov Gabriel Levin Florentin Racovitan Susie Lau Shannon Salvador Walter H Gotlieb Source Type: research